Antibiotics Explained: How They Fight Bacterial Infections
Antibiotics are medicines produced naturally by microorganisms (or made synthetically) that kill bacteria or stop their growth, curing bacterial infections. The era began with Alexander Fleming's 1928 discovery of penicillin from a mould contaminating his culture plate.
Understanding antibiotics matters because misuse is driving antibiotic resistance — a global health crisis. Knowing how they work explains why they fail against viruses and why completing the prescribed course is important.
Key Concepts
Bactericidal antibiotics kill bacteria (e.g., penicillin, aminoglycosides). Bacteriostatic antibiotics stop growth, letting immunity finish the job (e.g., tetracycline, erythromycin). Antibiotics target structures unique to bacteria: cell wall synthesis (beta-lactams bind penicillin-binding proteins), protein synthesis at 70S ribosomes (tetracyclines, macrolides, aminoglycosides), DNA replication (fluoroquinolones inhibit DNA gyrase), RNA synthesis (rifampicin), and folate synthesis (sulfonamides).
Spectrum: narrow-spectrum drugs act on few species; broad-spectrum act on many Gram-positive and Gram-negative bacteria. MIC (minimum inhibitory concentration) is the lowest drug concentration stopping visible growth.
- Beta-lactam ring: core structure of penicillins and cephalosporins, broken by bacterial beta-lactamase enzymes causing resistance.
- Selective toxicity: harming bacteria much more than human cells (our cells lack peptidoglycan and have 80S ribosomes).
How It Works
- The antibiotic reaches the infection site via blood at concentrations above MIC.
- It binds its bacterial target — e.g., penicillin blocks transpeptidase cross-linking peptidoglycan.
- Wall weakens, osmotic pressure bursts the cell (lysis) in bactericidal action, or growth halts in bacteriostatic action.
- Immune cells clear dead/weakened bacteria.
- Resistant mutants, if present, survive and multiply — especially if dose is too low or course incomplete.
Worked Example
Suppose an infection has 1 billion (10⁹) bacteria and a spontaneous resistance mutation rate of 1 in 10⁸ per division for a drug. Expected resistant cells initially ≈ 10⁹ / 10⁸ = 10 cells. If therapy uses one antibiotic, those 10 may survive and regrow. Using two antibiotics with different targets (as in tuberculosis therapy), combined probability is 1 in 10⁸ × 1 in 10⁸ = 1 in 10¹⁶, far exceeding the bacterial load, so no doubly resistant cell is expected. This arithmetic is why TB is treated with four drugs initially.
Common Misconceptions
- Misconception: Antibiotics cure viral cold and flu. Correction: Viruses have no cell wall or ribosomes of their own; antibiotics are useless and misuse breeds resistance.
- Misconception: Stop when you feel better. Correction: Early stopping leaves hardier bacteria alive; follow medical advice on duration (though modern guidance tailors length to infection, not arbitrary prolongation).
- Misconception: Stronger broad-spectrum is always better. Correction: It also kills gut flora, causing diarrhoea and resistance; narrow targeted therapy is preferred when the pathogen is known.
Real-World Applications
Doctors choose antibiotics based on Gram stain, culture, and sensitivity testing (disc diffusion, MIC). Surgeons give prophylactic antibiotics to prevent wound infection. Veterinarians and farms use antibiotics, though growth-promoter use is being restricted to curb resistance. New drug discovery screens soil microbes, while stewardship programs in hospitals audit prescriptions to preserve effectiveness.
Antibiotics exploit bacterial walls, 70S ribosomes, and enzymes to kill or halt pathogens with selective toxicity. Used correctly — right drug, dose, and duration — they save millions of lives; misused, they select resistance that threatens modern medicine.